Health Condition 1: null- Uncomplicated cataract patients undergoing phacoemulsification/small incision cataract surgery fulfilling the inclusion/exclusion criteria will be enrolled in the study.
Conditions
Interventions
Intervention1: Patients receiving topically Nepafenac 0.1%, eye drops thrice daily for 7 days.: To compare efficacy and saftey of topical Nepafenac 0.1% eye drop in reducing ocular pain and inflamma
Sponsors
Dr Saiyadali Allisabanavar
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients willing to give written informed consent. 2.Patients undergoing uncomplicated cataract surgery
Exclusion criteria
Exclusion criteria: 1.Surgeries other than phacoemulsification/small incisional cataract surgery. 2.Known sensitivity to any of the ingredients in the study medications. 3.Patients with preexisting ocular pathology, inflammation, tumor and glaucoma. 4.History of previous intraocular surgery, uveitis and iritis or intraocular inflammation in the study eye. 5.Use of steroids and Non steroidal inflammatory drugs by systemic route within the 14 days of surgery.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Conjunctival redness by conjunctival hyperemia score and lid edema by Lid edema scoringTimepoint: one week | — |
Primary
| Measure | Time frame |
|---|---|
| 1.Measuring percentage reduction in pain and is assessed by Visual analogue scale and Anterior Chamber Cells and flare by The Sun Working Group Grading Scheme .Timepoint: one week | — |
Countries
India
Contacts
Public ContactDr Narayana Reddy S
Bangalore medical college and research institute Bengaluru
Outcome results
None listed